CAGRILINTIDE 10MG
Cagrilintide | 10mg | Amylin Analog Peptide
For In Vitro Research Use Only — Not for Human or Veterinary Use
Description:
Cagrilintide is a synthetic, long-acting analogue of the pancreatic hormone amylin, modified for enhanced stability and prolonged half-life through lipidation and amino acid substitutions to reduce fibril formation. This peptide acts as a non-selective agonist for amylin and calcitonin receptors, promoting satiety, delaying gastric emptying, and suppressing appetite in research models. It is investigated for its potential in modeling obesity, type 2 diabetes, and metabolic regulation, often in combination with GLP-1 agonists for synergistic effects on weight loss and endocrine signaling. Provided in a 5mg lyophilized format, this compound is intended strictly for advanced laboratory-based in vitro applications.
Specifications:
-
Unit Size: 10mg (lyophilized powder, single vial)
-
Molecular Weight: ~4409 Da
-
Form: Lyophilized powder
- Storage: Store lyophilized peptide at 2°C–8°C in a dry, dark environment. After reconstitution, keep refrigerated between 2°C–8°C
Application Context:
Cagrilintide is researched for its potential influence on:
-
Appetite suppression and satiety signaling
-
Delayed gastric emptying and reduced food intake
-
Weight loss mechanisms and metabolic homeostasis
-
Synergistic effects with incretin mimetics in obesity models
Intended Use:
This product is intended solely for in vitro research use. It is not approved for use in humans or animals and may not be used in food, drugs, diagnostics, or cosmetics.